Daniel Ellis's research while affiliated with Molecular and Cellular Biology Program and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (24)
The head domain of influenza hemagglutinin (HA) elicits potently neutralizing yet mostly strain-specific antibodies during infection and vaccination. Here we evaluated a series of immunogens that combined several immunofocusing techniques for their ability to enhance the functional breadth of vaccine-elicited immune responses. We designed a series...
Immunogen design approaches aim to control the specificity and quality of antibody responses to enable the creation of next-generation vaccines with improved potency and breadth. However, our understanding of the relationship between immunogen structure and immunogenicity is limited. Here we use computational protein design to generate a self-assem...
Computationally designed protein nanoparticles have recently emerged as a promising platform for the development of new vaccines and biologics. For many applications, secretion of designed nanoparticles from eukaryotic cells would be advantageous, but in practice, they often secrete poorly. Here we show that designed hydrophobic interfaces that dri...
While the effort to vaccinate people against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has largely been successful, particularly in the developed world, the rise of new variants as well as waning immunity illustrate the need for a new generation of vaccines that provide broader and/or more durable protection against infection and...
Multivalent antigen display is a fast-growing area of interest towards broadly protective vaccines. Current nanoparticle-based vaccine candidates demonstrate the ability to confer antibody-mediated immunity against divergent strains of notably mutable viruses. In coronaviruses, this work is predominantly aimed at targeting conserved epitopes of the...
Protein nanoparticle scaffolds are increasingly used in next-generation vaccine designs and several have established records of clinical safety and efficacy. Yet the rules for how immune responses specific to nanoparticle scaffolds affect the immunogenicity of displayed antigens have not been established. Here we define relationships between anti-s...
Despite the remarkable efficacy of COVID-19 vaccines, waning immunity and the emergence of SARS-CoV-2 variants such as Omicron represents a global health challenge. Here, we present data from a study in nonhuman primates demonstrating durable protection against the Omicron BA.1 variant induced by a subunit SARS-CoV-2 vaccine comprising the receptor...
Computationally designed protein nanoparticles have recently emerged as a promising platform for the development of new vaccines and biologics. For many applications, secretion of designed nanoparticles from eukaryotic cells would be advantageous, but in practice they often secrete poorly. Here we show that designed hydrophobic interfaces that driv...
Influenza virus neuraminidase (NA) is a major antiviral drug target and has recently reemerged as a key target of antibody-mediated protective immunity. Here we show that recombinant NAs across non-bat subtypes adopt various tetrameric conformations, including an “open” state that may help explain poorly understood variations in NA stability across...
The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generati...
Influenza virus neuraminidase (NA) is a major antiviral drug target and has recently reemerged as a key target of antibody-mediated protective immunity. Here we show that recombinant NAs across all non-bat subtypes adopt various tetrameric conformations, including a previously unreported 'open' state that may help explain poorly understood variatio...
The unprecedented global demand for SARS-CoV-2 vaccines has demonstrated the need for highly effective vaccine candidates that are thermostable and amenable to large-scale manufacturing. Nanoparticle immunogens presenting the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (S) in repetitive arrays are being advanced as second-generati...
Influenza vaccines that confer broad and durable protection against diverse viral strains would have a major effect on global health, as they would lessen the need for annual vaccine reformulation and immunization¹. Here we show that computationally designed, two-component nanoparticle immunogens² induce potently neutralizing and broadly protective...
Recent advances in computational methods have enabled the predictive design of self-assembling protein nanomaterials with atomic-level accuracy. These design strategies focus exclusively on a single target structure, without consideration of the mechanism or dynamics of assembly. However, understanding the assembly process, and in particular its ro...
Multivalent presentation of viral glycoproteins can substantially increase the elicitation of antigen-specific antibodies. To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein trimers. We first de novo de...
Multivalent presentation of viral glycoproteins can substantially increase the elicitation of antigen-specific antibodies. To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein trimers. We first de novo de...
Multivalent presentation of viral glycoproteins can substantially increase the elicitation of antigen-specific antibodies. To enable a new generation of anti-viral vaccines, we designed self-assembling protein nanoparticles with geometries tailored to present the ectodomains of influenza, HIV, and RSV viral glycoprotein trimers. We first de novo de...
The receptor binding domain (RBD) of the SARS-CoV-2 spike glycoprotein mediates viral attachment to ACE2 receptor, and is a major determinant of host range and a dominant target of neutralizing antibodies. Here we experimentally measure how all amino-acid mutations to the RBD affect expression of folded protein and its affinity for ACE2. Most mutat...
Influenza vaccines that confer broad and durable protection against diverse virus strains would have a major impact on global health. However, next-generation vaccine design efforts have been complicated by challenges including the genetic plasticity of the virus and the immunodominance of certain epitopes in its glycoprotein antigens. Here we show...
The adaptive immune system is highly sensitive to arrayed antigens, and multivalent display of viral glycoproteins on symmetric scaffolds has been found to substantially increase the elicitation of antigen-specific antibodies. Motivated by the considerable promise of this strategy for next-generation anti-viral vaccines, we set out to design new se...
The development of native-like HIV-1 envelope (Env) trimer antigens has enabled the induction of neutralizing antibody (NAb) responses against neutralization-resistant HIV-1 strains in animal models. However, NAb responses are relatively weak and narrow in specificity. Displaying antigens in a multivalent fashion on nanoparticles (NPs) is an establ...
Technological advances in immunology, protein design, and genetic delivery have unlocked new possibilities for vaccine concepts and delivery technologies that were previously inaccessible. These next-generation vaccine design efforts are particularly promising in their potential to provide solutions to challenging targets for which conventional app...
The challenges of evolution in a complex biochemical environment, coupling genotype to phenotype and protecting the genetic material, are solved elegantly in biological systems by the encapsulation of nucleic acids. In the simplest examples, viruses use capsids to surround their genomes. Although these naturally occurring systems have been modified...
Designed to assemble
Symmetric macromolecular structures that form cages, such as viral capsids, have inspired protein engineering. Bale et al. used pairwise combinations of dimeric, trimeric, or pentameric building blocks to design two-component, 120-subunit protein complexes with three distinct icosahedral architectures. The capsid-like nanostruc...
Citations
... 2. Using experience gained from studies of the earlier SARS and MERS coronaviruses, it has been shown that introduction of two proline mutations (preS-2P) in the S2 domain prevents the spike protein from refolding to the post-fusion form and thereby stabilizes the prefusion form [58]. ...
Reference: In Silico Structure-Based Vaccine Design
... The addition of non-native N-linked glycans onto the H. pylori apoferritin scaffold was another engineered feature that contributed to augmenting the quality of the immune response. In contrast to a recent study that investigated the effect of scaffold glycosylation in the context of viral glycoprotein antigens 53 , we observed that in addition to dampening of the anti-scaffold response, glycan modification of the H. pylori apoferritin nanocage boosted anti-PfCSP responses and increased the frequency of PfCSP-reactive B cells compared to the non-glycosylated immunogen. Both effects were also evident in the BM plasma cell compartment indicating a long-lasting effect and qualitative difference in the response. ...
... Nanoparticle vaccine platforms allow multivalent antigen presentation and can elicit more potent immune responses than protein immunogens 17 . Several nanoparticle platforms using lumazine synthase, ferritin or I53-50 displaying SARS-CoV-2 spike or its RBD domain elicit potent nAb responses against SARS-CoV-2 [18][19][20][21] . HBsAg can self-assemble into a 22 nm nanoparticle and has been used successfully in multiple vaccines including Hepaccine B and Recombivax HB 22 . ...
... We started our pseudosymmetric design with a homotrimeric aldolase from the hyperthermophilic bacterium Thermotoga maritima that is remarkably stable and tolerant of modification (PDB ID 1WA3; 68 ). This trimer has previously been used to design multiple one-and two-component protein assemblies 12,16,69 , which as we show below makes possible the re-use of these previously designed interfaces in the creation of large pseudosymmetric assemblies. We set out to identify the minimum set of mutations necessary to drive 2 formation of a pseudosymmetric heterotrimer. ...
... Neuraminidase, located on the virus's surface and belongs to glycoproteins, next to HA and matrix protein2(M2), is also called sialidase [21]. NA is a tetramer of four identical polypeptides, presenting the mushroom-like structure consisting of four domains: an N-terminal cytoplasmic sequence, followed by a membrane-anchoring hydrophobic transmembrane domain (TMD) and a thin stalk of variable length, ending in a globular head domain, the binding site for sialic acid is located in the head domain [21][22][23][24]. Each protomer comprises approximately 470 amino acid residues [23]. ...
... Methods like the Degreaser that encode improved yield or performance in the sequence of the molecule itself are especially desirable, as they make the improvements "automatic": They do not require other actions like the use of specialized cell culture media or co-transfection of chaperones. Numerous examples of enzyme and antigen redesign to improve yield highlight the utility of this approach (19,(73)(74)(75)(76)(77)(78)(79)(80). Methods that encode improvements genetically are of increasing importance now that genetic delivery of biologics has become clinical reality with the recent licensure of several AAV-based gene therapies and mRNA vaccines (81,82). ...
... Structure-guided stabilization of the closed conformation was performed that improved thermal stability. More importantly, it also enhanced the affinity to protective antibodies elicited by viral infection, indicating that these antigens may elicit antibody responses to vulnerable quaternary epitopes more efficiently (149). ...
... The induction of a broad range of HI and neutralizing antibodies against the structural domains of the HA head and stem is an attractive target for the development of universal influenza vaccines. Vaccines that induce a broad range of antibodies are being developed as new universal influenza vaccines in various countries [10][11][12][13] . In addition, NA exhibits a slower rate of antigenic drift, which makes its antigenic sites more conservative, and antibodies to NA often show a broader cross-1 talk 14 , so optimizing influenza vaccines to improve the targeting of NA, and thus to protect different influenza strains consistently and broadly, is becoming a new direction in the development of universal influenza vaccines. ...
... While hydrophobic packing provides a strong driving force for assembly, it also tends to make the unassembled protein building blocks prone to aggregation, which can complicate their manufacture. By contrast, the interfaces in naturally occurring hierarchically structured protein complexes often include a higher fraction of polar residues, which maximizes assembly fidelity by minimizing off-target aggregation [28][29][30] . Methods capable of designing custom multi-component protein assemblies with native-like interfaces would promote the development of new protein-based technologies. ...
... Despite also sharing the N501Y mutation, omicron showed much weaker binding affinity than WT. A computational modeling study suggested that nine other mutations in the omicron RBD would decrease its binding affinity to ACE2 [64]. The weaker binding of omicron S protein to ACE2 implicates other interactions such as omicron's preference for cathepsin L instead of TMPRSS2 as the driving force behind its enhanced infectivity and transmissibility [65]. ...